NASDAQ:WVE WAVE Life Sciences (WVE) Stock Price, News & Analysis $2.56 -0.16 (-5.88%) Closing price 11/20/2026 04:00 PM EasternExtended Trading$2.66 +0.09 (+3.71%) As of 11/20/2026 07:33 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest About WAVE Life Sciences Stock (NASDAQ:WVE) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get WAVE Life Sciences alerts:Sign Up Key Stats Today's Range$2.55▼$2.7950-Day Range$2.56▼$4.5852-Week Range$2.55▼$21.73Volume2.28 million shsAverage Volume2.94 million shsMarket Capitalization$504.91 millionP/E RatioN/ADividend YieldN/APrice Target$20.44Consensus RatingModerate Buy Company Overview WAVE Life Sciences Ltd. is a biotechnology company developing RNA-based medicines for genetically defined diseases. Founded in 2012, the company is headquartered in Cambridge, Massachusetts, and uses its oligonucleotide chemistry and drug-design capabilities to develop treatments intended to alter or regulate gene expression. Its research includes antisense oligonucleotide therapies and RNA-editing approaches. Programs have targeted conditions such as Huntington’s disease and alpha-1 antitrypsin deficiency, with the latter exploring RNA editing to address a disease-causing genetic variant. WAVE’s work is focused on research and clinical development rather than a portfolio of marketed medicines. Its programs are designed to address serious diseases with limited treatment options, and the company evaluates its candidates through laboratory and clinical studies.AI Generated. May Contain Errors. Read More WAVE Life Sciences Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks51st Percentile Overall ScoreWVE MarketRank™: 2.560291643295 of 5 starsWAVE Life Sciences scored higher than 51% of companies evaluated by MarketBeat, and ranked 463rd out of 837 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion4.5 / 5Analyst RatingModerate Buy Consensus RatingWAVE Life Sciences has received a consensus rating of Moderate Buy. The company's average rating score is 2.90, and is based on 2 strong buy ratings, 15 buy ratings, 2 hold ratings, and 1 sell rating.Upside PotentialWAVE Life Sciences has a consensus price target of $20.44, representing about 698.6% upside from its current price of $2.56.Amount of Analyst CoverageWAVE Life Sciences has been the subject of 8 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about WAVE Life Sciences' stock forecast and price target. Earnings and Valuation0.0 / 5Proj. Earnings GrowthDecreasing Earnings GrowthEarnings for WAVE Life Sciences are expected to decrease in the coming year, from ($1.08) to ($1.18) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of WAVE Life Sciences is -2.39, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of WAVE Life Sciences is -2.39, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioWAVE Life Sciences has a P/B Ratio of 1.25. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Short Interest2.0 / 5Short Interest LevelBearish Percentage of Shares Shorted13.84% of the float of WAVE Life Sciences has been sold short.Short Interest Ratio / Days to CoverWAVE Life Sciences has a short interest ratio ("days to cover") of 6.76.Change versus previous monthShort interest in WAVE Life Sciences has recently decreased by 2.45%, indicating that investor sentiment is improving. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldWAVE Life Sciences does not currently pay a dividend.Dividend GrowthWAVE Life Sciences does not have a long track record of dividend growth. News and Social Media1.7 / 5News Sentiment-0.23 News SentimentWAVE Life Sciences has a news sentiment score of -0.23. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.41 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 3 news articles for WAVE Life Sciences this week, compared to 6 articles on an average week.Search InterestOnly 5 people have searched for WVE on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.MarketBeat Follows6 people have added WAVE Life Sciences to their MarketBeat watchlist in the last 30 days. This is an increase of 200% compared to the previous 30 days. Company Ownership1.4 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, WAVE Life Sciences insiders have not sold or bought any company stock.Percentage Held by Insiders24.34% of the stock of WAVE Life Sciences is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions89.73% of the stock of WAVE Life Sciences is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about WAVE Life Sciences' insider trading history. Receive WVE Stock News and Ratings via Email Sign-up to receive the latest news and ratings for WAVE Life Sciences and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. WVE Stock News HeadlinesWAVE Life Sciences (NASDAQ:WVE) Reaches New 12-Month Low on Analyst DowngradeNovember 15, 2026 | americanbankingnews.comCitigroup Issues Pessimistic Forecast for WAVE Life Sciences (NASDAQ:WVE) Stock PriceNovember 14, 2026 | americanbankingnews.comYour $7 scanner is waitingThe Instant Scanner is $7 in Bill Poulos's Black Friday sale. Every night it delivers a list showing which stock, what price, and when to exit. The list reads the same whether you've traded for twenty years or twenty days, and it doesn't depend on account size. If it's not for you, refund the $7 and still keep the scanner for the full year. One payment, no re-bills.November 22 at 1:00 AM | Profits Run (Ad)Wave Life Sciences Highlights WVE-007 (INHBE siRNA) Progress at ObesityWeek® 2026November 13, 2026 | globenewswire.comWave Life Sciences to Present at Jefferies Global Healthcare Conference in LondonNovember 11, 2026 | globenewswire.comWave Life Sciences: Reversing Stock Losses Tricky Despite Near-Term AATD ReadoutNovember 10, 2026 | seekingalpha.comWave Life Sciences, Inc. (WVE) Research Day: RNA Medicines Platform and Pipeline Innovation - SlideshowNovember 9, 2026 | seekingalpha.comWave: 3 Key Takeaways for Long-Term InvestorsNovember 8, 2026 | fool.comSee More Headlines WVE Stock Analysis - Frequently Asked Questions How have WVE shares performed this year? WAVE Life Sciences' stock was trading at $17.00 on January 1st, 2026. Since then, WVE stock has decreased by 84.9% and is now trading at $2.56. How were WAVE Life Sciences' earnings last quarter? WAVE Life Sciences Ltd. (NASDAQ:WVE) released its earnings results on Wednesday, October, 28th. The company reported ($0.30) earnings per share for the quarter, beating the consensus estimate of ($0.33) by $0.03. The firm had revenue of $13.16 million for the quarter, compared to analysts' expectations of $4.51 million. WAVE Life Sciences had a negative net margin of 296.86% and a negative trailing twelve-month return on equity of 44.66%. Read the conference call transcript. When did WAVE Life Sciences IPO? WAVE Life Sciences (WVE) raised $102 million in an initial public offering (IPO) on Wednesday, November 11th 2015. The company issued 6,375,000 shares at $15.00-$17.00 per share. Who are WAVE Life Sciences' major shareholders? WAVE Life Sciences' top institutional investors include State Street Corp (2.87%), Readystate Asset Management LP (2.81%), Marshall Wace LLP (1.86%) and Algert Global LLC (1.03%). Insiders that own company stock include Ra Capital Management, LP, Plc Gsk, Chandra Vargeese, Paul Bolno, Gregory L Verdine, Kyle Moran, Chris Francis, Heidi L Wagner, Mark Corrigan, Ken Takanashi, Christian O Henry and Adrian Rawcliffe. View institutional ownership trends. How do I buy shares of WAVE Life Sciences? Shares of WVE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of WAVE Life Sciences own? Based on aggregate information from My MarketBeat watchlists, some other companies that WAVE Life Sciences investors own include NVIDIA (NVDA), Micron Technology (MU), Tesla (TSLA), Oracle (ORCL), Advanced Micro Devices (AMD), Broadcom (AVGO) and Applied Materials (AMAT). Company Calendar Last Earnings10/28/2026Today11/21/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Red Zone (8m+) 1-Year History Nov 25 Feb 26 May 26 Aug 26 Nov 26 WVE's financial health is in the Red zone, according to TradeSmith. WVE has been in this zone for over 8 months. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Biotechnology Sub-IndustryBiotechnology Current SymbolNASDAQ:WVE CIK1631574 Webwww.wavelifesciences.com Phone(656) 236-3388Fax617-949-2901Employees317Year Founded2012Price Target and Rating Average Price Target for WAVE Life Sciences$20.44 High Price Target$43.00 Low Price Target$10.00 Potential Upside/Downside+698.6%Consensus RatingModerate Buy Rating Score (0-4)2.90 Research Coverage20 Analysts Profitability EPS (Trailing Twelve Months)($1.07) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$204.38 million Net Margins-296.86% Pretax Margin-296.86% Return on Equity-44.66% Return on Assets-36.80% Debt Debt-to-Equity RatioN/A Current Ratio8.38 Quick Ratio8.38 Sales & Book Value Annual Sales$42.73 million Price / Sales11.82 Cash FlowN/A Price / Cash FlowN/A Book Value$2.04 per share Price / Book1.25Miscellaneous Outstanding Shares197,230,000Free Float149,223,000Market Cap$504.91 million OptionableOptionable Beta-1.40 Social Links The 7 Hottest IPO Stories of 2026MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.Get This Free Report This page (NASDAQ:WVE) was last updated on 11/20/2026 by MarketBeat.com Staff. From Our PartnersPrediction: NVDA will “snap back” on this dateOthers paid $500 for the Snapback Indicator. For Black Friday, Base Camp Trading is offering lifetime access f...Base Camp Trading | SponsoredYour $7 scanner is waitingThe Instant Scanner is $7 in Bill Poulos's Black Friday sale. Every night it delivers a list showing which sto...Profits Run | SponsoredELON + YOU + DECEMBER 8THElon Musk's next big project may be the most ambitious move of his career, and all signs point to December 8th...Paradigm Press | SponsoredCFA: Bank of America Said THISOn January 24th, 2022, Bank of America told Bloomberg something that should terrify every American with a savi...Decentralized Masters | SponsoredWhat the hell is going on?Porter Stansberry says President Trump is quietly replacing the U.S. dollar without a vote in Congress, and th...Porter & Company | SponsoredGold Miners Post Record Cash Flows as AI Stocks WobbleGold miners are posting record cash flows, outperforming every other sector, yet mining still makes up just 1%...Golden Portfolio | SponsoredFinancial legend: “This is bad, really bad...”Dr. Martin D. Weiss has publicly predicted six major American financial crashes over his 55-year career leadin...Weiss Ratings | SponsoredNoah’s Ark found?Scientists may have discovered Noah's Ark buried under a mountain in eastern Turkey, just two miles from the I...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding WAVE Life Sciences Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share WAVE Life Sciences With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.